Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Type of study
Language
Year range
1.
Rev. colomb. reumatol ; 29(1): 26-30, Jan.-Mar. 2022. tab, graf
Article in English | LILACS | ID: biblio-1423900

ABSTRACT

ABSTRACT Introduction: Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE. Objective: To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE. Methods: A cross-sectional descriptive study was conducted. Treatment adherence was eval uated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety). Results: A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence. Conclusion: This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.


RESUMEN Introducción: El lupus eritematoso sistémico (LES) es una enfermedad crónica que afecta a múltiples sistemas, entre ellos el sistema nervioso, con eventos neurológicos y psiquiátricos que podrían influir en la adherencia al tratamiento y los resultados a largo plazo de la enfermedad. Objetivo: Evaluar la adherencia al tratamiento de los pacientes con trastornos neuropsiquiátricos difusos asociados con el LES. Metodología: Se llevó a cabo un estudio descriptivo transversal que evaluó el grado de adhe rencia al tratamiento con el test de Morisky en pacientes con trastornos neuropsiquiátricos difusos asociados con LES (alteración cognitiva, psicosis, trastornos del ánimo y ansiedad). Resultados: Se incluyó a 60 pacientes con trastornos neuropsiquiátricos difusos asociados con LES, de los cuales 13 (21,6%) tuvieron adherencia alta, 9 (15%) adherencia media y 38 (63,3%) presentaron baja adherencia al tratamiento. Conclusión: En este estudio se identificó que más de la mitad de los participantes (63,3%) presentaron baja adherencia al tratamiento.


Subject(s)
Humans , Adolescent , Adult , Behavioral Sciences , Skin and Connective Tissue Diseases , Connective Tissue Diseases , Behavioral Disciplines and Activities , Neuropsychiatry , Lupus Erythematosus, Systemic
SELECTION OF CITATIONS
SEARCH DETAIL